Newly discovered microRNA regulates mobility of tumor cells

Newly discovered microRNA regulates mobility of tumor cells
Epithelial breast cancer cells following treatment with an EMT activator: they adopt the properties of mesenchymal cells; in addition, individual cells break away from the cell cluster and migrate into the surrounding tissue. Blue: nucleus, green: paxillin (adhesion protein), red: actin (cytoskeleton). Credit: University of Basel, Department of Biomedicine

Cancer cells can reactivate a cellular process that is an essential part of embryonic development. This allows them to leave the primary tumor, penetrate the surrounding tissue and form metastases in peripheral organs. In the journal Nature Communications, researchers from the University of Basel's Department of Biomedicine provide an insight into the molecular networks that regulate this process.

During an embryo's development, epithelial cells can break away from the cell cluster, modify their cell type-specific properties, and migrate into other regions to form the desired structures there. This process, which is known as an epithelial–mesenchymal transition (EMT), is reversible and can also proceed in the direction from to (MET). It is repeated multiple times during and ultimately paves the way for the formation of organs in the human body.

Tumor cells can reactivate the program

Although this is a completely normal process during embryogenesis, it also plays an important role in the spread of within the body and in the formation of metastases. As a result, this cellular program has also attracted greater attention in the field of tumor research in recent years.

Tumor cells are able to reactivate the EMT/MET program. By doing so, they obtain characteristics of stem cells and develop increased resistance to not only classical but also state-of-the-art targeted cancer therapies.

An EMT also makes it easier for to break away from the , to penetrate into surrounding tissue and into blood vessels, to spread throughout the body and to form metastases in distant organs, which is ultimately responsible for the death of most cancer patients.

The research group, led by Professor Gerhard Christofori from the University of Basel's Department of Biomedicine, researches the molecular processes that regulate the cellular EMT program. By doing so, they aim to demonstrate new intervention strategies to combat the development of malignant tumors and the formation of metastases – such as in the case of breast cancer, one of the most common and malicious diseases in women.

Newly discovered microRNA inhibits EMT

In a study published in the latest edition of Nature Communications, the researchers focused specifically on microRNAs (miRNAs), a class of very short non-coding RNAs with a considerable effect on gene regulation. They identified a hitherto unknown microRNA, miR-1199-5p, that induces epithelial cell behavior and impedes the malignancy of tumor cells, as well as their potential to form secondary tumors.

In concrete terms, the newly discovered microRNA prevents the synthesis of a specific protein, the transcription factor Zeb1, which activates EMT/MET – but if it is missing, the EMT process is prevented. Zeb1 also suppresses the expression of miR1199-5p in what is known as a negative feedback loop, whereby the two molecules regulate one another reciprocally.

More and more often, molecular switches of this kind are being found within processes that cause to alter or lose their cell type-specific properties. They appear to be responsible for a rapid, reversible cellular response to extracellular stimuli.

In the future, these insights into the for regulating EMT/MET plasticity may allow the development of new strategies for the treatment of breast cancer.


Explore further

How a non-coding RNA encourages cancer growth and metastasis

More information: Maren Diepenbruck et al. miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis, Nature Communications (2017). DOI: 10.1038/s41467-017-01197-w
Provided by University of Basel
Citation: Newly discovered microRNA regulates mobility of tumor cells (2017, October 27) retrieved 20 February 2019 from https://medicalxpress.com/news/2017-10-newly-microrna-mobility-tumor-cells.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more